Argireline Research: What 45 Studies Show (2026) | RetatrutideCompare

Argireline — 45 studies indexed on PubMed. Mimics the N-terminus of SNAP-25 and competes for SNARE complex assembly, dampening neurotransmitter release at the neuromuscular junction (proposed wrinkle-reduction mechanism). Half-life: Minutes (topical, local action). FDA status: Cosmetic ingredient; not FDA-approved as drug.

PubMed search-result count last fetched 2026-06-18. Records may include reviews, laboratory work, and animal studies; this is not a clinical trial count or a measure of efficacy.

Inspect the PubMed query and results

How many studies have been published on Argireline?

There are approximately 45 studies indexed on PubMed that mention Argireline (Acetyl Hexapeptide-3, Acetyl Hexapeptide-8), based on a search last updated 2026-06-18.

Is Argireline FDA-approved?

FDA status: Cosmetic ingredient; not FDA-approved as drug.

How does Argireline work?

Mimics the N-terminus of SNAP-25 and competes for SNARE complex assembly, dampening neurotransmitter release at the neuromuscular junction (proposed wrinkle-reduction mechanism).

Reference facts

Also known as: Acetyl Hexapeptide-3, Acetyl Hexapeptide-8
Category: Cosmetic & Skin
Mechanism of action: Mimics the N-terminus of SNAP-25 and competes for SNARE complex assembly, dampening neurotransmitter release at the neuromuscular junction (proposed wrinkle-reduction mechanism).
Targets: SNARE complex (in vitro)
Indications under research or approved: Cosmetic anti-wrinkle topical formulations
Regulatory status (reference entry): Cosmetic ingredient; not FDA-approved as drug
Half-life: Minutes (topical, local action)
Sequence: EEMQRR
Sequence notes: Hexapeptide Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2; mimics the N-terminus of SNAP-25.
Molecular weight (Da): 889
Originator / sponsor: Lipotec / Lubrizol
First reported: 2002

Primary References

Blanes-Mira et al., Int J Cosmet Sci 2002 (Argireline)

Explore research articles about Argireline

This is an educational reference, not medical advice. Research findings do not establish safety or efficacy for self-administration. Consult the primary sources for study populations, limitations, and current regulatory status.